Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Open, Uncontrolled Study to Investigate the Efficacy and Safety of the Oral Contraceptive SH T 186 D Containing 0.02 mg Ethinylestradiol-b-cyclodextrin Clathrate and 3 mg Drospirenone in a 24-day Regimen for 13 Cycles in 1010 Healthy Female Volunteers

NCT00185484 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT00185484
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00185484 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Open, Uncontrolled Study to Investigate the Efficacy and Safety of the Oral Contraceptive SH T 186 D Containing 0.02 mg Ethinylestradiol-b-cyclodextrin Clathrate and 3 mg Drospirenone in a 24-day Regimen for 13 Cycles in 1010 Healthy Female Volunteers
Lead sponsor
Bayer
Phase
Phase 3
Overall status
Completed
Start date
March 31, 2004
Completion date
January 31, 2006
Enrollment
1,113 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

contraception